Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Gene therapy -- Ignore unavailable to you. Want to Upgrade?

To: scott_jiminez who wrote (231)	9/5/2000 9:56:54 AM
From: Mike McFarland	Read Replies (1) \| Respond to of 319

I still get the CCBN alerts--a nice move today on Ariad. Sure wish I'd held on longer during the January romp (especially on my 65k of warrants! I saw your message on the aria thread--heck I was in to a lot of warrants near the lows...but sadly, out of all by $3 or so, most closer to $2, ha!) Okay, back on the topic of gene therapy, I just discovered a recent HSV-tk Savio Woo patent. Patent Number 6066624 Issue Date 2000 05 23 Assignee Baylor College of Medicine Inventor(s) Woo, Savio L. C. Chen, Shu-Hsia Title Gene therapy for solid tumors using adenoviral vectors comprising suicide genes and cytokine genes Bibliography--six papers here include Woo invivogen.com Still available for non-exclusive or exclusive license?? bcm.tmc.edu Ariad CIDs artp.org A past Baylor company was GeneMedicine, now Valentis bcm.tmc.edu (also GeneSwitch w/ Baylor) but Valentis doesn't really have a vector for this I would guess (?). More on that Baylor patent follows Abstract The present invention provides a novel method of treating localized solid tumors and papillomas in an individual, as well as metastatic carcinomas. The method comprises delivering a suicide gene, by way of a recombinant adenoviral vector or other DNA transport system, into the tumor, papilloma or wart of an individual. Subsequently, a prodrug, such as the drug gaciclovir.TM., is administered to the individual. Additionally, the present invention provides a method for treating solid tumors, papillomas, warts and metastatic carcinomas, said method comprising introducing both a suicide gene and one or more cytokine genes into the tumor, papilloma or wart of an individual, and subsequently administering a prodrug to the individual. The methods of the present invention may be used to treat several different types of cancers and papillomas, including colon carcinoma, prostate cancer, breast cancer, lung cancer, melanoma, hepatoma, brain lymphoma and head and neck cancer. Exmp. Claim 1 Ex Claim text A method of causing regression of a solid tumor in a mammal, comprising the steps of: administering an adenoviral vector directly into said tumor, wherein said vector is comprised of a DNA sequence encoding a suicide gene, and one or more cytokine genes, wherein said genes are operably linked to a promoter, and wherein said tumor expresses said suicide gene and said one or more cytokine genes; and administering a prodrug in amounts sufficient to cause regression of said tumor when said prodrug is converted to a toxic compound by said suicide gene.